0001104659-19-059064.txt : 20191210 0001104659-19-059064.hdr.sgml : 20191210 20191101180902 ACCESSION NUMBER: 0001104659-19-059064 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 CORRESP 1 filename1.htm

 

Collegium Pharmaceutical, Inc.
100 Technology Center Drive

Stoughton, MA 02072

 

November 1, 2019

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re:                             Collegium Pharmaceutical, Inc.

Registration Statement on Form S-3
Filed October 25, 2019 (File No. 333-234329)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Collegium Pharmaceutical, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-234329) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 PM, eastern time, on November 6, 2019, or as soon as thereafter as is practicable.

 

Please contact Jennifer L. Porter, Esq. of Pepper Hamilton LLP, counsel to the Company, at (215) 981-4339 to provide notice of effectiveness, or if you have any questions or comments concerning this request.

 

[Remainder of the page intentionally left blank]

 

 

 

 

Very truly yours,

 

 

 

 

 

COLLEGIUM PHARMACEUTICAL, INC.

 

 

 

 

By:

/s/ Shirley R. Kuhlmann

 

 

Name:

Shirley R. Kuhlmann

 

 

Title:

Executive Vice President, General Counsel and Secretary

 

Collegium Pharmaceutical, Inc. — Acceleration Letter